Clinical Trial Update: A Six-Month Follow-Up Study of Participants With Coronavirus Disease 2019 (COVID-19) Previously Enrolled in a RO7496998 (AT-527) Study

View source ↗

Summary

A six-month follow-up of participants previously enrolled in a RO7496998 (AT-527) study for COVID-19, with the study terminated and results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Long Covid

Drugs mentioned

• RO7496998 (AT-527)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: COVID-19, Long COVID | Status: TERMINATED | Results posted: 2023-07-28